Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Q Fang

Showing results (351-360 of 416) with videos related to

Pageof 42
Sort By:
Pediatric Diabetes|December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onsetS A Litherland, J X She, D Schatz, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell TherapyGohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
Frontiers in Immunology|February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomasGohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
ESMO Open|June 10, 2025
Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06R Shami, R Salgado, A Bardia, et al.
Nature Communications|May 18, 2021
Observation of topological superconductivity in a stoichiometric transition metal dichalcogenide 2M-WS<sub>2</sub>Y W Li, H J Zheng, Y Q Fang, et al.
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
A broad-spectrum antiviral targeting entry of enveloped virusesMike C Wolf, Alexander N Freiberg, Tinghu Zhang, et al.
Blood|March 13, 2026
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysisMichael Oertel, Bouthaina S Dabaja, Dennis Görlich, et al.
Blood Advances|April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter StudyNikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Physical Review Letters|November 20, 2020
Large Isospin Asymmetry in ^{22}Si/^{22}O Mirror Gamow-Teller Transitions Reveals the Halo Structure of ^{22}AlJ Lee, X X Xu, K Kaneko, et al.
Pageof 42

Showing results (351-360 of 416) with videos related to

Sort By:
Pageof 42
Pediatric Diabetes|December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onsetS A Litherland, J X She, D Schatz, et al.
International Journal of Radiation Oncology, Biology, Physics|September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell TherapyGohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
Frontiers in Immunology|February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomasGohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
ESMO Open|June 10, 2025
Analytical and clinical validation of PATHWAY HER2 (4B5) assay for assessment of HER2-low/HER2-ultralow status and eligibility for trastuzumab deruxtecan in DESTINY-Breast06R Shami, R Salgado, A Bardia, et al.
Nature Communications|May 18, 2021
Observation of topological superconductivity in a stoichiometric transition metal dichalcogenide 2M-WS<sub>2</sub>Y W Li, H J Zheng, Y Q Fang, et al.
The Lancet. Haematology|June 6, 2024
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trialJillian R Gunther, Jie Xu, Manoop S Bhutani, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
A broad-spectrum antiviral targeting entry of enveloped virusesMike C Wolf, Alexander N Freiberg, Tinghu Zhang, et al.
Blood|March 13, 2026
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysisMichael Oertel, Bouthaina S Dabaja, Dennis Görlich, et al.
Blood Advances|April 9, 2025
Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cells for B-Cell Lymphomas: An ILROG Multicenter StudyNikhil Yegya-Raman, John P Plastaras, Christopher M Wright, et al.
Physical Review Letters|November 20, 2020
Large Isospin Asymmetry in ^{22}Si/^{22}O Mirror Gamow-Teller Transitions Reveals the Halo Structure of ^{22}AlJ Lee, X X Xu, K Kaneko, et al.
Pageof 42